XOMA Royalty (XOMA) Treasury Shares (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Treasury Shares came in at $841442.0 in Q1 2026, up 40.92% year-on-year from $597117.0 in Q1 2025, and up 2718.43% quarter-over-quarter from $29855.0 in Q4 2025.
XOMA Royalty (XOMA) Treasury Shares (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Treasury Shares across 12 years of filings, most recently posting $841442.0 for Q1 2026.
- Treasury Shares for Q1 2026 came in at $841442.0, up 40.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $841442.0 (up 40.92% YoY), and the FY2025 annual result was $29855.0, down 95.0% from the prior year.
- Treasury Shares came in at $841442.0 for Q1 2026 at XOMA Royalty, up from $29855.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $841442.0 in Q1 2026 to a low of $15175.0 in Q2 2024.
- The 4-year median for Treasury Shares is $439500.0 (2023), against an average of $437553.2.
- Across the five-year window, Treasury Shares slumped 96.47% in 2024 and jumped 96.74% in 2025, its largest moves.
- XOMA Royalty's Treasury Shares stood at $448600.0 in 2023, then surged by 33.11% to $597117.0 in 2024, then tumbled by 95.0% to $29855.0 in 2025, then soared by 2718.43% to $841442.0 in 2026.
- The last three Treasury Shares figures came in at $841442.0 (Q1 2026), $29855.0 (Q4 2025), and $373477.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 841,442.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 841,442.00 |
| Mar 31, 2026 | 841,442.00 |
| Dec 31, 2025 | 29,855.00 |
| Dec 31, 2025 | 29,855.00 |
| Sep 30, 2025 | 373,477.00 |
| Sep 30, 2025 | 373,477.00 |
| Jun 30, 2025 | 29,855.00 |
| Jun 30, 2025 | 29,855.00 |
| Mar 31, 2025 | 597,117.00 |
| Mar 31, 2025 | 597,117.00 |
| Dec 31, 2024 | 597,117.00 |
| Dec 31, 2024 | 597,117.00 |
| Sep 30, 2024 | 733,600.00 |
| Sep 30, 2024 | 733,600.00 |
| Jun 30, 2024 | 15,175.00 |
| Jun 30, 2024 | 15,175.00 |
| Mar 31, 2024 | 723,600.00 |
| Mar 31, 2024 | 723,600.00 |
| Dec 31, 2023 | 448,600.00 |
| Dec 31, 2023 | 448,600.00 |